Evidence map›Paper›PMID 42832670›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Tyrosine phosphorylation unfolds nucleophosmin and disrupts its integration into the nucleolus.

Rafael L Giner-Arroyo, Adrián Velázquez-Campoy, Miguel A De la Rosa, Irene Díaz-Moreno

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rafael L Giner-ArroyoInstitute for Chemical Research - Scientific Research Center "Isla de la Cartuja" (cicCartuja), University of Seville - Spanish National Research Council, Seville 41092, Spain.ORCID 0000-0003-2651-7916
Adrián Velázquez-CampoyInstitute for Biocomputation and Physics of Complex Systems, and Department of Biochemistry and Molecular and Cell Biology, University of Zaragoza, Zaragoza 50018, Spain.ORCID 0000-0001-5702-4538
Miguel A De la RosaInstitute for Chemical Research - Scientific Research Center "Isla de la Cartuja" (cicCartuja), University of Seville - Spanish National Research Council, Seville 41092, Spain.ORCID 0000-0003-1187-5737
Irene Díaz-MorenoInstitute for Chemical Research - Scientific Research Center "Isla de la Cartuja" (cicCartuja), University of Seville - Spanish National Research Council, Seville 41092, Spain.ORCID 0000-0002-5318-7644

Funding

Ramon Areces Foundation LEUCYTO-FRA2025-MARSpanish State Research Agency (AEI) PID2021-126663NB-I00Spanish State Research Agency (AEI) PID2024-157414NB-I00Spanish State Research Agency (AEI) PRE2019-091404
6 · The paper itself

Abstract

Nucleophosmin (NPM1) is a multifunctional nucleolar protein essential for ribosome biogenesis, genome stability, and stress responses. Its integration into the nucleolus depends on its oligomerization and multivalent interactions that enable liquid-liquid phase separation (LLPS). Here, we investigate how tyrosine phosphorylation at Tyr17, Tyr29, and Tyr67 located within the interface between monomers at the N-terminal oligomerization domain regulates NPM1 structure and function. Replacing tyrosines with

Indexed as

Cell NucleolusNuclear ProteinsTyrosineHumansNucleophosminPhase SeparationPhosphorylationTumor Suppressor Protein p53NPM1 protein, humanNuclear ProteinsNucleophosminTumor Suppressor Protein p53Tyrosineliquid-liquid phase separationnucleolusnucleophosminprotein oligomerizationtyrosine phosphorylation

Identifiers

PMID42832670
PMCPMC13663732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.